Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vibration therapy may boost walking recovery after stroke

NCT ID NCT05945212

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding gentle vibrations to the leg muscles can help people recovering from a stroke walk faster. About 70 patients who had a stroke within the past 3 months will either get real vibrations or a fake treatment during their regular rehab. The goal is to see if the vibrations improve walking speed and overall recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke) * Presenting with a stroke, ischemic or hemorrhagic * Lower-limb deficiency with an initial motor testing \< 4 according to the MRC scale * No neurological history with functional impact other than stroke * Having received informed information about the study and having signed the written consent * Affiliated or entitled to a social security scheme. * Patients under guardianship may be included; they may give their consent with the assistance of their guardian. If the participant is unable to write, their consent may be given and documented by other appropriate means in the presence of at least one impartial witness. In this case, the witness will sign and date the informed consent document. Exclusion Criteria: * Multiple stroke * Other neurological, cognitive or psychiatric conditions * Orthopedic ankle history compromising measurements * Botulinum toxin injected in the lower limb prior the study protocol * Patient with phlebitis or risk of thrombosis in the lower limb * Patient under tutorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke rehabilitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier Georges Claudinon

    NOT_YET_RECRUITING

    Le Chambon-Feugerolles, 42500, France

  • Centre Hospitalier de Roanne

    NOT_YET_RECRUITING

    Roanne, 42300, France

  • Hospices Civils de Lyon, site Henry Gabrielle

    NOT_YET_RECRUITING

    Saint-Genis-Laval, 69230, France

  • Hôpital Bellevue, CHU de Saint-etienne

    RECRUITING

    Saint-Etienne, 42100, France

  • Hôpital Marrel

    RECRUITING

    Rive-de-Gier, 42800, France

  • Service de SSR Val-Rosay

    NOT_YET_RECRUITING

    Saint-Didier-au-Mont-d'Or, 69370, France

  • Service de SSR du Centre Le Clos Champirol

    NOT_YET_RECRUITING

    Saint-Etienne, 42270, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.